Академический Документы
Профессиональный Документы
Культура Документы
Eye on India
Facts fight back
Event
Q2FY14 earnings preview: Its not so bad, after all. Our analysts predict
revenue growth of 10% YoY and EBITDA growth of 11% with EBITDA margins expanding ~40bps. PAT growth is expected to be more muted at 3% due to a high interest burden and mark to market losses on forex. The market is geared up for a washed out quarter and this could surprise.
Export oriented sectors dominate: IT sector is a standout, followed by
Autos (Tata Motors), Media, Pharma and Consumer. Cement sector is expected to be the worst performer. Buy HCL Tech, Ranbaxy, Tata Steel and Reliance on results. Sell Ambuja Cement, Ultratech and SBI.
Ranbaxy RBXY IN OP 362 550 JSPL JSP IN OP 241 350 L&T LT IN OP 828 1163 ITC ITC IN OP 338 421 Idea Cellular IDEA IN OP 176 215 Coal India COAL IN OP 303 360 ICICI Bank ICICIBC IN OP 938 1115 HCL Tech HCLT IN OP 1104 1300 M&M MM IN OP 851 1000 Tata Motors TTMT IN OP 345 380 Source: Macquarie Research, Oct 2013; Prices as of close on Oct 3, 2013
Impact
Revenue growth to buck the trend: After 5 quarters of downtrend in
revenue growth, we estimate revenue growth to clock 10% growth driven by all round good performance by sectors except Cement and Infra. IT sector is the leader with 23% revenue growth, but Autos, Media, Consumer, Pharma and Properties etc may show revenue growth in mid teens. Clearly both exports and rural demand is doing much better than expected.
EBITDA margins remain stable: EBITDA margins have largely stabilised
around 20% level. Despite the low demand, companies have done well to hold on to operating margins. Rupee depreciation has come as a blessing in disguise and companies are looking to export the surplus production to beat low domestic demand.
Net profit lagging behind: Net profit growth has been scraping the bottom as
companies deal with forex MTM losses as well as rising interest costs. However, with the rupee now looking to stabilise, we expect net profit growth to be stronger from Q3.
Selective earnings upgrades: The overall market is still witnessing earnings
Fund flows
US$ m Latest 1W (Oct 1) Total 1M Total YTD Total FII -14 -59 1904 13389 Domestic MFs -65 -39 -467 -2991 FII Net Stock Futures -32 -77 -685 3015 FII Net Index Futures 38 47 1348 -952 FII Net Derivative Buys 92 21 66 10686 Source: Bloomberg, Macquarie Research, Oct 2013
downgrades with earnings revision ratio well below 1. Cement and Banks, including the private sector, are going through a sharp downgrade cycle. However, a few bright spots can be found in IT, Pharma and Telecom. Media and Metals & Mining sectors are also seeing some upgrades.
Standout stocks: HCL Tech, Idea Cellular, Sun Pharma and Reliance
Industries are seeing EPS upgrades, while Maruti, SBI, BHEL and SAIL continue to see sharp downgrades.
Outlook
Markets can gain momentum with results: Infosys kick starts the results
Analyst(s)
Rakesh Arora, CFA +91 22 6720 4093 rakesh.arora@macquarie.com Arjun Bhattacharya +91 22 6720 4095 arjun.bhattacharya@macquarie.com
on 11th and will likely set a positive tone for the market. Exports are picking up and so is rural demand. Whether Modi mania translates into votes in the upcoming state elections is the key question in Nov. Overall, the market seems set to continue its upward journey. Buy on the dips.
4 October 2013
Macquarie Capital Securities India (Pvt) Ltd Please refer to the important disclosures and analyst certification on inside back cover of this document, or on our website www.macquarie.com.au/disclosures.
Macquarie Research
Eye on India
For the quarter ended September 2013, our analysts are estimating 10% YoY revenue growth,
11% YoY EBITDA growth and 3% YoY PAT growth for our coverage universe (ex oil & gas). The large divergence in bottom-line growth vis--vis top-line and operating income growth suggests that high interest costs and impact from currency volatility may have had a role to play. In particular, stocks with maximum impact below the operating level are Adani Power, JSW Steel and SBI (due to higher provisions). Excluding these, profit growth improves to 6.3% yoy.
Overall, only 4 sectors are expected to contribute significantly to overall net profit growth these
are telecom, IT, consumer and autos. Amongst financials, PSU banks are expected to be a drag on growth with a 6% decline in profits while private banks are expected to show 12% increase in profits. On the negative side, cement, power (Adani, NTPC), real estate and pharma (CIPLA, Ranbaxy, Wockhardt) would likely be the worst performing sectors on profit growth. Amongst these, only cement is expected to show a decline in revenues on a yoy basis.
Our analysts are forecasting EBITDA margins (ex oil & gas, fin) to improve by ~40bps, with
positive contribution primarily from power, media, telecom, consumer, autos, IT and metals and negative contribution from real estate, cement, pharma, and infra/capital goods.
For Sensex, we expect aggregate revenue and EBITDA to grow at 10% YoY while profits are
expected to grow 2%, dragged down by M&M, BHEL, JSPL, CIPLA, ONGC, SBI and NTPC with maximum impact from the last 3 stocks. Excluding these three, profit growth improves dramatically to 10% yoy. For Sensex too, EBITDA margins (ex-ONGC, GAIL, financials) are expected to be flat compared to the previous year.
Fig 1 Estimated Q2FY14 Revenue Growth by sector (Macquarie coverage ex-Oil & gas)
25% 20% 16% 15% 15% 10% 6% 5% 0% -5% -10% -7%
IT Au to s M ed Fi na ia nc ia Pr ls op er C on ty su m e Ph r ar m a Po w Te er le co m M In fra eta ls /C ap G ds C To em e ta l ( nt ex -O il)
Fig 2 Estimated Q2FY14 PAT Growth by sector (Macquarie coverage ex-Oil & gas)
40%
23%
Revenue Growth (% yoy)
30% 20%
13%
12% 12%
10% 5% 4% 1%
3%
-3%
Fig 3 Estimated Q2FY14 EBITDA Growth (% yoy) (Macquarie coverage ex-Oil & gas)
30% 20% 10% 0% -10% -20% -21% -30%
IT Au to s M ed C on ia su m er Po w Fi er na nc ia Te ls le co m M et al Ph s ar m a Pr op In fra er ty /C ap G ds C To em e ta l ( nt ex -O il)
Fig 4 Estimated Q2FY14 Change in EBITDA Margin (Macquarie coverage ex-Oil & gas, Financials)
300 207 200 178 142 112
Change in EBITDA Margins (yoy, bps)
10% 10% 6% 3% 2%
11%
100 0 -100
-8%
4 October 2013
Te l
Te l
Macquarie Research
Eye on India
Fig 6 Quarterly EBITDA Margins - Macquarie Coverage Universe (ex-Oil & Gas, Fin)
24.0% EBITDA Margins (ex-Oil & Gas, Financials) 23.0% 22.6% 22.0% 21.0% 20.0% 19.0% 18.0% 17.0% Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 20.4% 19.5% 19.8% 22.3% 21.3% 21.6% 20.5% 20.7% 19.8% 19.4% 20.4% 20.6% 20.0%
Fig 7 Trend in Revenue, EBITDA and PAT BSE-100 (ex Oil, Fin), 4Q Rolling
4Q Rolling, % yoy 60.0% 50.0% 40.0% 30.0% 20.0% 10.0% 0.0% -10.0% Net Profit Growth (lhs) Revenue Growth (lhs) 4Q Rolling, % EBITDA Margin (rhs) 19.0% 18.0% 17.0% 16.0% 15.0% 14.0% 13.0% 12.0% 11.0% 10.0%
Feb-06
Feb-07
Feb-08
Feb-09
Feb-10
Feb-11
Feb-12
Feb-13
Oct-05
Oct-06
Oct-07
Oct-08
Oct-09
Oct-10
Oct-11
Jun-05
Jun-06
Jun-07
Jun-08
Jun-09
Jun-10
Jun-11
Jun-12
Oct-12
4 October 2013
Jun-13
Macquarie Research
Eye on India
Fig 9
400.0
35.0
45.0
150.0 100.0
50.0
50.0 0.0
Sep-03
Mar-05
Sep-06
Mar-08
Sep-09
Mar-11
Sep-12
4 October 2013
Macquarie Research
Eye on India
Fig 11
3.00 2.50 2.00 1.50 1.00 0.50
0.00 Jan-05 Oct-05 Jul-06 Apr-07 Jan-08 Oct-08 Jul-09 Apr-10 Jan-11 Oct-11 Jul-12 Apr-13
Fig 12
1.80 1.60
Autos
Fig 13
Media
1.40
Autos
1.40
3 Month Moving Average
Dec-11
Apr-12
Aug-12
Dec-12
Apr-13
Aug-13
Dec-11
Apr-12
Aug-12
Dec-12
Apr-13
Aug-13
Fig 14
4.00
Consumer Staples
Fig 15
1.60 1.40
Energy
Dec-11
Apr-12
Aug-12
Dec-12
Apr-13
Aug-13
Dec-11
Apr-12
Aug-12
Dec-12
Apr-13
Aug-13
4 October 2013
Macquarie Research
Eye on India
Fig 16
1.20
Real Estate
Fig 17
5.00 1.00
Real Estate 3 Month Moving Average
4.50 4.00
0.80
0.60
Dec-11
Apr-12
Aug-12
Dec-12
Apr-13
Aug-13
Dec-11
Apr-12
Aug-12
Dec-12
Apr-13
Aug-13
Fig 18
PSU Banks
Fig 19
NBFCs
1.60 1.40 1.20 1.00 0.80 0.60 0.40 0.20 0.00 Aug-11
Dec-11
Apr-12
Aug-12
Dec-12
Apr-13
Aug-13
Dec-11
Apr-12
Aug-12
Dec-12
Apr-13
Aug-13
Fig 20
Healthcare
Fig 21
1.20
Industrials
2.00 1.80 1.60 1.40 1.20 1.00 0.80 0.60 0.40 0.20 0.00 Aug-11 0.00 Aug-11
Health Care 3 Month Moving Average
1.00
Industrials 3 Month Moving Average
0.80
0.60
0.40
0.20
Dec-11
Apr-12
Aug-12
Dec-12
Apr-13
Aug-13
Dec-11
Apr-12
Aug-12
Dec-12
Apr-13
Aug-13
4 October 2013
Macquarie Research
Eye on India
Fig 22
Information Technology
Fig 23
5.00
Cement
18.00 4.50 16.00 14.00 12.00 10.00 8.00 6.00 4.00 2.00 0.00 Aug-11
Information Technology 3 Month Moving Average
4.00 3.50 3.00 2.50 2.00 1.50 1.00 0.50 0.00 Aug-11
Dec-11
Apr-12
Aug-12
Dec-12
Apr-13
Aug-13
Dec-11
Apr-12
Aug-12
Dec-12
Apr-13
Aug-13
Fig 24
1.20 1.00
Fig 25
Telecom
2.50
Telecom 3 Month Moving Average
2.00
Metals & Mining
0.80 0.60
1.50
Dec-11
Apr-12
Aug-12
Dec-12
Apr-13
Aug-13
0.00 Aug-11
Dec-11
Apr-12
Aug-12
Dec-12
Apr-13
Aug-13
Fig 26
Utilities
1.60 1.40
Utilities
Dec-11
Apr-12
Aug-12
Dec-12
Apr-13
Aug-13
4 October 2013
Macquarie Research
Eye on India
Fig 27
Company
Coverage Stocks with high Positive and Negative 3-Month % EPS Revisions
Bloomberg Code 3M % EPS Revision 3M Stock Perf Mkt Cap (US$ m) Rating Price Price Target
POSITIVE REVISIONS Large Cap (>US$2bn) HCL Technologies Idea Cellular Sun Pharmaceuticals Wipro Tata Consultancy Services Cairn India Infosys Technologies Reliance Industries Lupin Tata Motors HCLT IN IDEA IN SUNP IN WPRO IN TCS IN CAIR IN INFO IN RIL IN LPC IN TTMT IN 20.6% 16.1% 11.5% 11.3% 10.7% 10.3% 8.6% 3.8% 3.5% 3.0% 45.4% 21.8% 19.6% 38.0% 35.7% 11.5% 24.2% -4.2% 10.8% 19.0% 12435 9416 20106 19298 64027 10082 28067 44167 6231 17940 Outperform Outperform Outperform Neutral Outperform Outperform Outperform Outperform Neutral Outperform 1104 176 601 485 2024 327 3039 846 861 345 1300 215 675 480 2200 378 3550 1100 860 380
Mid Cap (between US$500m and US$2bn) MindTree MTCL IN Hexaware Technologies HEXW IN D.B. Corp. DBCL IN Reliance Capital RCAPT IN Mphasis MPHL IN Small Cap (below US$500m) Welspun Corp Punj Lloyd Gujarat Pipavav Port Aban Offshore Persistent Systems NEGATIVE REVISIONS Large Cap (>US$2bn) JSW Steel Maruti Suzuki India Bharat Heavy Electricals State Bank of India Steel Authority of India Jindal Steel and Power Indian Oil Siemens India Tata Power Ranbaxy Laboratories JSTL IN MSIL IN BHEL IN SBIN IN SAIL IN JSP IN IOCL IN SIEM IN TPWR IN RBXY IN
31 24 46 225 643
59 17 59 222 620
-14.7% -15.1% -15.9% -16.1% -16.6% -16.9% -20.8% -24.1% -24.9% -42.5%
15.6% -12.0% -19.6% -17.7% 4.8% 7.7% -12.0% -13.9% -8.2% 11.6%
2978 6895 5687 18348 3655 3637 8161 2834 3112 2475
Outperform Neutral Underperform Neutral Neutral Outperform Outperform Underperform Outperform Outperform
Mid Cap (between US$500m and US$2bn) Union Bank of India UNBK IN Wockhardt WPL IN L&T Finance Holdings Ltd LTFH IN Unitech UT IN ABB India ABB IN IDBI IDBI IN Canara Bank CBK IN Jaiprakash Associates JPA IN Ashok Leyland AL IN Adani Power ADANI IN Small Cap (below US$500m) Nagarjuna Construction Co Indiabulls Real Estate Godrej Properties Jaypee Infratech Jubilant Lifesciences Limited Anant Raj Industries Jindal Saw Limited Gujarat NRE Coke HDIL India Cements
-13.2% -14.0% -14.0% -15.7% -20.9% -22.3% -24.6% -44.1% -105.3% -247.9%
-39.9% -56.0% -17.2% -29.9% -11.0% -17.0% -38.7% -32.6% -27.1% -22.2%
1117 835 1843 689 1895 1320 1687 1347 647 1541
Underperform Neutral Underperform Underperform Underperform Underperform Underperform Underperform Outperform Underperform
NJCC IN IBREL IN GPL IN JPIN IN JOL IN ARCP IN JSAW IN GNC IN HDIL IN ICEM IN
-10.0% -10.1% -10.2% -13.0% -16.1% -16.3% -17.3% -17.9% -23.0% -29.6%
-32.4% -17.5% -27.5% -33.5% -41.7% -24.2% -26.8% -8.3% -6.1% -11.4%
Underperform Underperform Outperform Outperform Outperform Outperform Outperform Outperform Outperform Neutral
19 57 361 17 79 42 45 13 39 53
4 October 2013
4 October 2013 9
Macquarie Research
Fig 28
Company name Automobiles Ashok Leyland Bajaj Auto Eicher Motors Ltd. Hero MotoCorp Mahindra & Mahindra Maruti Suzuki India Tata Motors Total Banks** Axis Bank Bank of Baroda Bank of India Canara Bank HDFC Bank HDFC ICICI Bank IDBI IndusInd Bank Ltd. IDFC Kotak Mahindra Bank L&T Finance Holdings Ltd LIC Housing Finance Mahindra & Mahindra Fin. Services Power Finance Punjab National Bank Reliance Capital Rural Electrification Shriram Transport Finance State Bank of India Union Bank of India Yes Bank Total Cement Ambuja Cements Associated Cements Grasim Industries India Cements Ultratech Cements Total Infrastructure ABB India Adani Ports and SEZ Bharat Heavy Electricals Crompton Greaves India Cummins India Gujarat Pipavav Port Jaiprakash Associates Larsen & Toubro Nagarjuna Construction Company
46,746 40,485 35,880 29,503 60,539 21,220 60,226 22,452 10,526 8,362 26,098 5,247 5,099 6,911 18,824 49,936 15,654 16,881 9,981 159,982 26,163 10,252 686,967
19% 10% 16% 15% 19% 22% 11% 16% 31% -2% 1% 32% 25% 20% 28% 10% -16% 25% 10% 12% 9% 28% 13%
1% -2% -3% -9% -5% 18% -4% 2% -8% -18% -4% 6% 1% 2% 2% -5% 19% -4% 1% 0% -2% -7% -2%
26,193 24,527 19,891 15,526 29,972 19,606 34,242 13,571 5,602 6,936 6,298 3,577 4,270 4,484 18,387 26,684 1,960 16,008 7,638 74,291 13,020 6,202 378,883
20% 3% 7% 21% 41% 23% 7% 15% 33% -4% -20% 36% 26% 20% 28% 5% -64% 25% 7% 1% 2% 28% 10%
-8% 0% -9% -18% -9% 20% -10% 3% -13% -21% -43% 22% -3% 2% 1% -10% 30% -3% 4% -2% -8% -9% -6%
13,463 11,120 7,625 6,874 18,162 13,888 21,824 3,900 2,996 4,266 3,953 1,752 2,975 2,332 12,656 11,504 1,515 11,303 3,342 28,572 4,949 3,452 192,425
20% -15% 153% 4% 16% 21% 12% -19% 20% -10% -22% 22% 22% 21% 22% 8% -62% 18% -1% -22% -11% 13% 3%
-4% -5% -21% -13% -1% 18% -4% 27% -11% -23% -38% 21% -4% 14% 6% -10% 19% -2% -2% -12% -12% -14% -6%
Eye on India
4 October 2013 10
Macquarie Research
Fig 28
Company name Punj Lloyd Siemens India Thermax Total Consumer Dabur Emami Godrej Consumer Products Ltd. Hindustan Unilever ITC Marico United Spirits Total Information Technology HCL Technologies Hexaware Technologies Infosys Technologies Mindtree Mphasis Persistent Systems Rolta India Tata Consultancy Services Wipro Total Metals Hindalco Industries National Aluminium Company Hindustan Zinc Coal India Gujarat NRE Coke NMDC Jindal Steel and Power JSW Steel Tata Steel Steel Authority of India Total Petroleum Aban Offshore Bharat Petroleum Cairn India Essar Oil Ltd. GAIL India Hindustan Petroleum Indian Oil Oil and Natural Gas Corporation Oil India Petronet LNG Reliance Industries Total 28,000 37,127 12,501 434,127
7% 6% 11% 2% 9% -7% 9% 6%
78,965 6,106 127,233 7,609 16,784 4,071 6,279 208,292 105,353 560,691
30% 20% 29% 28% 28% 25% 34% 33% -1% 23%
18,862 1,485 33,971 1,598 3,137 957 2,418 62,417 23,179 148,024
13,065 1,061 26,698 1,198 2,133 518 665 44,410 17,636 107,385
68,020 14,955 32,690 152,194 3,686 24,049 40,987 103,510 342,741 118,805 901,636
4,379 2,216 17,330 27,010 643 16,237 13,119 17,418 31,755 9,170 139,278
-15% 1022% 24% -6% -41% -16% -17% 17% 37% -4% 6%
3,249 1,680 17,524 30,748 (77) 14,202 5,237 1,268 2,407 4,658 80,897
-9% 3415% 14% 0% -146% -15% -37% -82% 166% -14% -3%
9,863 666,399 50,900 259,190 133,160 529,780 1,278,893 227,088 25,584 108,286 1,004,333 4,293,476
11% 13% 25% 15% 3% 2% 16% 18% 22% 29% 15% 14%
5,313 16,639 37,612 4,196 16,475 (7,805) 46,231 114,088 11,584 4,210 72,390 320,933
11% 78% 29% -52% 9% -13% 497% 34% 42% 6% -8% 43%
848 9,539 31,744 (5,083) 9,129 (15,905) 17,874 46,957 8,358 2,412 53,912 159,784
72% -81% 37% -584% -7% -168% -81% -20% -12% -23% 0% -52%
Eye on India
4 October 2013 11
Macquarie Research
Fig 28
Company name Power Adani Power CESC Limited JSW Energy NTPC Power Grid Corporation of India Tata Power Total Properties Anant Raj Industries DLF Godrej Properties HDIL Indiabulls Real Estate Jaypee Infratech Oberoi Realty Omaxe Phoenix Mills Prestige Estates Sobha Developers Unitech Total Telecom Bharti Airtel Idea Cellular Total Media Dish TV India D.B. Corp. HT Media Jagran Prakashan Zee Entertainment Enterprises Zee News Total Pharma Apollo Hospitals Cipla Dr. Reddy's Laboratories Fortis Healthcare Glaxosmithkline Pharmaceuticals Glenmark Pharmaceuticals Jubilant Lifesciences Limited Lupin Piramal Enterprises Ranbaxy Laboratories Sun Pharmaceuticals Wockhardt Total
961 21,415 2,560 2,327 5,500 7,347 2,577 4,155 731 5,000 4,480 6,737 63,789
336 8,031 640 2,327 1,650 3,606 1,417 623 512 1,300 1,344 1,010 22,796
222 1,171 330 388 899 893 1,066 236 392 838 552 798 7,785
-56% -15% 1% -72% 179% -51% -14% 5% 19% 83% 10% 62% -14%
15% -35% -16% 139% 24% 10% 5% 24% -6% -3% 10% 27% 1%
1% 21% 5%
1% -2% 0%
3% 40% 10%
1% -4% -1%
18% -9% 8%
4% 1% 0% 7% 12% 6% 6%
9,200 23,450 32,000 12,300 6,485 14,857 13,650 26,600 9,800 27,000 37,835 12,150 227,827
10% 7% 10% -18% -4% 18% 11% 16% 14% 2% 42% -10% 12%
1,520 5,630 7,000 500 1,235 3,107 2,355 6,375 1,425 3,025 16,735 3,230 52,637
6% -17% 2% -76% -40% 27% -10% 24% 95% -13% 42% -38% 4%
845 4,040 4,250 (715) 1,050 1,852 750 4,350 (955) 1,490 12,595 2,440 31,992
2% -19% 3% -151% -38% 47% -27% 50% -4% -80% 45% -46% -12%
Eye on India
4 October 2013 12
Macquarie Research
Fig 28
Company name Macquarie's total universe Macquarie's total universe (excl Oil & Gas) Source: Macquarie Research, October 2013 9,067,855 4,774,379
Eye on India
4 October 2013 13
Macquarie Research
Fig 29
Sector (Analyst)
Rating Outperform Underperform Underperform Underperform Underperform Outperform Outperform Underperform Outperform Outperform Outperform Underperform Underperform Underperform Outperform Underperform Outperform Neutral Neutral Neutral Underperform Outperform
Banks (Suresh Ganapathy/Parag Jariwala) Axis Bank AXSB IN Bank of Baroda BOB IN Bank of India BOI IN Canara bank CBK IN HDFC HDFC IN HDFC Bank HDFCB IN ICICI Bank ICICIBC IN IDBI IDBI IN IDFC IDFC IN Indusind Bank IIB IN Kotak Mahindra Bank KMB IN L&T Finance Holdings LTFH IN LIC Housing Finance LICHF IN Mahindra & Mahindra Fin. MMFS IN Services Power Finance Corp POWF IN Punjab National Bank PNB IN Reliance Capital RCAPT IN Rural Electrification RECL IN SBI SBIN IN Shriram Transport SHTF IN Finance Union Bank UNBK IN Yes Bank YES IN Cement (Rakesh Arora/Sumangal Nevatia) ACC ACC IN Ambuja Cements ACEM IN Grasim Industries GRASIM IN India Cements ICEM IN Ultratech Cements UTCEM IN
12 17 8 12 12
Construction (Inderjeetsingh Bhatia/Amit Sinha) ABB India ABB IN 552 Adani Ports and SEZ ADSEZ IN 141 BHEL BHEL IN 144 Crompton Greaves India CRG IN 91 GMR Infrastructure GMRI IN 22 Gujarat Pipavav Port GPPV IN 46 GVK Power & GVKP IN 7 Infrastructure J.P. Associates JPA IN 38 Larsen & Toubro LT IN 829 Nagarjuna Construction NJCC IN 19 Punj Lloyd PUNJ IN 24 Siemens India SIEM IN 492
-31% 28% -8% -1% 11% 29% 34% 1% 40% -25% -29% -22%
1,881 4,663 5,616 941 1,409 353 163 1,336 12,256 76 128 2,815
1.26 5.45 15.46 3.94 2.84 0.27 0.45 27.69 41.39 0.55 2.86 3.21
25.5 16.2 9.3 14.8 (27.6) 9.5 (9.0) 16.0 14.5 7.1 9.5 25.5
20.1 13.3 10.8 9.7 27.5 8.8 8.7 10.7 10.4 6.9 6.4 20.2
3.5 3.3 1.1 1.5 1.0 1.4 0.3 0.6 2.0 0.2 0.3 3.3
3.0 2.7 1.0 1.3 0.9 1.2 0.3 0.6 1.8 0.2 0.3 2.9
14.4 23.5 12.0 10.6 -3.5 15.8 -3.5 3.9 16.6 2.5 2.8 13.5
Underperform Outperform Underperform Neutral Outperform Outperform Outperform Underperform Outperform Underperform Underperform Underperform
Eye on India
4 October 2013 14
Macquarie Research
Fig 29
Sector (Analyst)
Rating Outperform Outperform Outperform Outperform Outperform Neutral Outperform Outperform Neutral
Information Technology (Nitin Mohta/Atul Soni) HCL Technologies HCLT IN 1,072 Hexaware HEXW IN 129 Infosys Technologies INFO IN 3,015 Mindtree MTCL IN 1,198 Mphasis MPHL IN 454 Persistent PSYS IN 631 Rolta India RLTA IN 56 TCS TCS IN 1,946 Wipro WPRO IN 471 Media (Nitin Mohta/Atul Soni) DB Corp DBCL IN Dish TV DITV IN HT Media HTML IN Jagran Prakashan JAGP IN Zee Entertainment Z IN Zee News ZEEN IN Metals (Rakesh Arora/Sumangal Nevatia) Coal India COAL IN Gujarat NRE Coke GNC IN Hindalco HNDL IN Hindustan Zinc HZ IN Jindal Steel & Power JSP IN JSW Steel JSTL IN NALCO NACL IN NMDC NMDC IN SAIL SAIL IN Tata Steel TATA IN Oil & Gas (Abhishek Agarwal) Aban Offshore ABAN IN Bharat Petroleum BPCL IN Cairn India CAIR IN Essar Oil ESOIL IN GAIL GAIL IN Hindustan Petroleum HPCL IN Indian Oil Corp IOCL IN Oil & Natural Gas Corp. ONGC IN Oil India OINL IN Petronet LNG PLNG IN Reliance Industries RIL IN
253 53 85 80 246 12
25 nmf 18 -4 27 12
19% 37% 25% 13% 45% 11% -28% 23% -12% 17%
30,694 127 3,534 9,072 3,582 2,970 1,383 7,881 3,602 4,463
13.04 0.13 13.86 1.99 15.41 14.09 0.23 5.63 3.51 30.59
10.3 12.1 9.0 7.9 7.8 9.6 13.8 7.7 11.8 9.0
8.9 2.7 7.1 7.2 4.9 8.5 11.3 7.1 10.1 6.7
3.1 0.4 0.6 1.5 0.9 0.9 0.7 1.6 0.5 0.8
2.7 0.4 0.6 1.3 0.8 0.9 0.7 1.5 0.5 0.7
32.9 4.4 7.3 20.5 12.8 10.4 5.2 22.1 4.5 8.7
11 33 1 8 25 9 15 5 -6 253
Outperform Outperform Outperform Outperform Outperform Outperform Underperform Outperform Neutral Outperform
225 335 327 54 333 191 208 267 459 121 847
-2% 26% 16% 79% 17% 34% 44% 35% 42% -21% 30%
157 3,871 9,991 1,163 6,763 1,034 8,030 36,471 4,397 1,453 43,645
1.46 7.88 11.66 1.70 5.94 4.25 2.38 20.95 4.53 2.08 52.62
3.0 15.7 5.2 4.5 9.8 7.0 6.8 8.0 6.9 10.0 11.1
2.2 11.5 5.4 3.1 8.7 4.3 6.0 6.6 6.1 8.6 10.2
0.3 1.4 1.1 1.3 1.3 0.5 0.7 1.6 1.3 2.0 1.2
0.3 1.3 0.9 0.9 1.2 0.4 0.7 1.4 1.1 1.7 1.1
8.3 9.1 21.8 38.1 14.3 6.7 11.3 19.1 19.8 20.2 11.7
72 -1 2 nmf 6 158 38 20 12 -4 9
Neutral Outperform Outperform Outperform Outperform Outperform Outperform Outperform Outperform Underperform Outperform
Pharmaceuticals (Abhishek Singhal/Kumar Saurabh) Apollo Hospitals APHS IN 909 Cipla CIPLA IN 436 Dr. Reddys Labs DRRD IN 2,430 Fortis Healthcare FORH IN 98 GlaxoSmithKline Pharma GLXO IN 2,467 Glenmark GNP IN 539 Jubilant JOL IN 79
29 13 18 nmf 13 26 15
Eye on India
4 October 2013 15
Macquarie Research
Fig 29
Sector (Analyst) Lupin Piramal Ranbaxy Strides Arcolab Sun Pharma Wockhardt
Properties (Abhishek Bhandari) Anant Raj ARCP IN DLF DLFU IN Godrej Properties GPL IN HDIL HDIL IN Indiabulls Real Estate IBREL IN Jaypee Infratech JPIN IN Oberoi Realty OBER IN Omaxe OAXE IN Phoenix Mills PHNX IN Prestige Estates PEPL IN Sobha Developers SOBHA IN Unitech UT IN Consumer (Amit Mishra) Dabur DABUR IN Emami HMN IN Godrej Consumer GCPL IN Hindustan Unilever HUVR IN ITC ITC IN Marico Industries MRCO IN United Spirits UNSP IN
186% 45% 40% 10% -15% 64% 37% -14% 16% 49% 30% -27%
199 3,955 575 260 386 370 899 382 526 662 456 683
0.94 29.71 0.23 14.11 7.43 0.46 0.43 0.84 0.27 0.70 0.84 13.33
7.0 23.3 15.0 2.4 7.2 6.7 11.1 12.1 16.4 11.2 8.5 6.6
8.2 18.6 11.5 2.0 7.0 8.3 6.6 5.1 10.8 10.1 6.8 8.3
0.3 0.8 1.5 0.1 0.3 0.3 1.2 1.1 1.7 1.3 1.2 0.4
0.3 0.8 1.3 0.1 0.3 0.3 1.1 0.9 1.5 1.2 1.1 0.3
4.4 3.7 12.9 6.4 4.5 5.2 11.6 9.5 10.8 12.7 14.8 5.5
-3 30 38 26 40 -37 30 51 90 17 39 29
Outperform Outperform Outperform Outperform Underperform Outperform Outperform Underperform Outperform Outperform Outperform Underperform
14 20 26 10 19 18 140
Telecom (Abhishek Singhal/Kumar Saurabh) Bharti Airtel BHARTI IN 324 Idea Cellular IDEA IN 176 Autos (Amit Mishra) Ashok Leyland Bajaj Auto Eicher Motors Hero Honda Mahindra & Mahindra Maruti Suzuki Tata Motors
425 215
31% 22%
20,690 9,286
24.94 13.73
30.7 32.3
23.4 23.2
2.1 3.6
2.0 3.1
7.6 11.8
52 58
Outperform Outperform
Power (Inderjeet Bhatia/Amit Sinha) Adani Power ADANI IN CESC CESC IN JSW Energy JSW IN NTPC NTPC IN Power Grid Corporation PWGR IN Tata Power TPWR IN
nmf 5 -8 9 8 67
Eye on India
Source: Bloomberg, Macquarie Research, October 2013; Prices as of October 3, 2013 close
Macquarie Research
Eye on India
Company Coal India HCL Technologies ICICI Bank Idea Cellular ITC Jindal Steel and Power Larsen & Toubro Mahindra & Mahindra Ranbaxy Laboratories Tata Motors Top-10 Focus List Aggregate* MSCI India Sensex Nifty
Note: Average returns are equal-weighted and there are no transaction costs involved. Source: Bloomberg, Macquarie Research, October 2013; Prices as of October 3, 2013 close
Fig 31
Date
12/11/2010 12/11/2010 12/11/2010 26/11/2010 12/01/2011 30/05/2011 30/05/2011 30/05/2011 30/05/2011 25/08/2011 25/08/2011 28/11/2011 12/01/2012 12/01/2012 10/05/2012 10/05/2012 29/06/2012 26/07/2012 27/09/2012 14/01/2013 14/01/2013 14/01/2013 11-07-2013 11-07-2013 11-07-2013 19-08-2013 29-08-2013 29-08-2013
4 October 2013
16
Macquarie Research
Eye on India
Dec-10
Apr-11
Aug-11
Dec-11
Apr-12
Aug-12
Dec-12
Apr-13
Aug-13
4 October 2013
17
Macquarie Research
Eye on India
Fig 33
Sector/Company Macquarie Model Portfolio MSCI India Sensex NIFTY Consumer Staples Hindustan Unilever Ltd ITC Ltd Consumer Discretionary Mahindra & Mahindra Ltd Tata Motors Ltd Energy Coal India Ltd Oil & Natural Gas Corp Ltd Reliance Industries Ltd Bharat Petroleum Corp Ltd Financials Axis Bank DLF Ltd HDFC Bank Ltd ICICI Bank Ltd HDFC Ltd State Bank of India Health Care Glenmark Pharma Sun Pharma Ranbaxy Laboratories Ltd Dr Reddy's Laboratories Ltd Industrials Cummins India Larsen & Toubro Ltd Information Technology Infosys Ltd Tata Consultancy Services Ltd HCL Technologies Ltd Materials NMDC Ltd Jindal Steel & Power Ltd Tata Steel Ltd Telecom. Services Bharti Airtel Ltd Idea Cellular Ltd Utilities Power Grid Corp of India Ltd NTPC Ltd
Ticker MACQ Index MXIN Index Sensex Index Nifty Index MXIN0CS Index HUVR IN Equity ITC IN Equity MXIN0CD Index MM IN Equity TTMT IN Equity MXIN0EN Index COAL IN Equity ONGC IN Equity RIL IN Equity BPCL IN Equity MXIN0FN Index AXSB IN Equity DLFU IN Equity HDFCB IN Equity ICICIBC IN Equity HDFC IN Equity SBIN IN Equity MXIN0HC Index GNP IN Equity SUNP IN Equity RBXY IN Equity DRRD IN Equity MXIN0IN Index KKC IN Equity LT IN Equity MXIN0IT Index INFO IN Equity TCS IN Equity HCLT IN Equity MXIN0MT Index NMDC IN Equity JSP IN Equity TATA IN Equity MXIN0TC Index BHARTI IN Equity IDEA IN Equity MXIN0UT Index PWGR IN Equity NTPC IN Equity
1w 1.0 0.7 0.0 0.5 -1.6 -3.1 -3.0 1.5 0.0 0.7 0.7 -0.5 -3.8 1.0 8.4 1.1 7.1 2.6 2.4 -0.9 1.2 -0.9 0.8 3.2 3.4 7.5 -1.1 -0.3 -0.3 -0.1 2.3 0.8 4.2 5.0 0.6 -2.3 2.3 -4.7 -1.6 -3.1 1.6 -1.4 0.6 -3.9
6m -2.7 7.0 7.9 6.6 20.1 27.6 15.7 16.7 1.4 34.8 1.9 -2.1 -14.8 7.3 -11.9 -6.2 -8.2 -40.4 1.9 -5.2 5.8 -18.4 18.2 9.8 38.9 -17.8 25.5 -11.1 -17.7 -6.2 20.4 7.2 36.7 48.2 5.5 0.2 -27.1 -6.6 43.2 15.6 64.7 -1.3 -4.1 2.2
1Y -10.3 0.2 1.6 -0.7 16.6 14.9 17.9 -1.5 -9.6 9.2 -2.3 -16.0 -0.4 0.7 -5.9 -17.4 -18.9 -40.9 -7.1 -19.0 -3.7 -31.6 23.3 0.1 62.5 -28.8 32.4 -29.0 -21.1 -23.5 43.8 31.5 60.2 77.5 -17.3 -26.4 -47.7 -34.8 30.0 0.7 69.7 -16.4 -12.3 -7.5
9.3 3.7 5.6 6.5 4.0 2.5 14.2 1.5 2.1 8.5 2.1 23.3 3.0 1.0 8.3 4.0 4.5 2.5 8.5 1.2 2.5 3.0 1.8 4.5 1.5 3.0 21.5 9.5 7.0 5.0 5.7 2.1 2.9 0.7 3.5 1.5 2.0 3.0 1.6 2.0
11.5 3.1 5.2 6.1 1.9 1.8 12.6 1.0 1.5 8.5 0.4 24.9 1.9 0.4 6.8 2.7 7.9 1.6 7.3 0.0 2.5 0.4 1.8 3.6 0.0 1.8 21.5 11.1 7.1 1.6 6.3 0.0 0.7 0.7 2.6 1.4 0.8 3.7 0.9 1.1
105.6 53.5 49.3 56.2 38.5 74.3 -14.7 -7.2 -16.5 -12.5 -1.2 -7.7 -20.3 -55.4 45.1 -4.7 15.4 -9.9 78.1 6.4 63.4 5.8 7.6 -51.8 -17.3 -32.9 44.3 9.6 132.4 31.4 -25.2 6.4 -65.5 2.7 -47.6 -12.7 35.1 -38.5 -7.6 -3.7
* Returns are weighted for Model Portfolio and unweighted for individual stocks and there are no transaction costs involved; Period performance of individual stocks reflects actual price performance Source: Bloomberg, Macquarie Research, October 2013. Prices as of October 3, 2013 close.
4 October 2013
18
Macquarie Research
Eye on India
41.3 32.7 -0.5 18.0 -19.1 -42.0 -23.7 -2.1 -26.3 -22.2 -15.1 -24.9 14.6 -23.1
2.6 1.8 1.6 1.2 1.0 0.9 -0.1 -0.1 -0.5 -1.2 -1.3 -1.4 -1.7 -2.2
-0.8 1.4 10.1 5.8 15.2 6.4 7.0 1.5 14.5 7.3 13.1 8.8 7.7 10.4
28.6 22.9 5.1 5.8 -10.8 -19.0 -4.3 -5.0 -11.7 13.3 -3.2 -8.1 -0.1 -5.5
19.1 19.4 17.4 17.0 -9.3 -31.1 -15.8 0.8 -10.8 1.4 0.3 -15.2 16.3 -7.6
33.7 31.1 9.0 27.4 -13.1 -37.0 -17.2 -5.4 -29.0 -19.0 -15.0 -27.0 20.9 -26.8
43.9 -0.7 -16.5 23.8 -2.0 -15.9 -28.0 -15.9 31.7 17.6
2.3 1.5 1.1 0.8 0.7 0.6 -0.3 -1.4 -1.6 -1.6
-1.4 9.8 12.9 7.0 2.0 10.6 15.4 8.9 11.0 6.8
28.3 3.6 -9.9 8.0 -3.0 10.1 -12.1 -1.8 13.3 0.2
19.0 16.4 -7.7 19.3 3.9 5.3 -11.8 -0.9 46.6 19.8
34.3 9.3 -11.0 30.8 -4.5 -11.4 -29.6 -20.0 56.6 23.5
Source: Bloomberg, Macquarie Research, October 2013. Prices as of October 3, 2013 close
Fig 35
MSCI India MSCI Asia ex-Japan MSCI EM MSCI China MSCI World MSCI US MSCI Europe MSCI UK MSCI Japan
Source: Bloomberg, Macquarie Research, October 2013; Prices as of October 3, 2013 close
4 October 2013
19
Macquarie Research
Eye on India
Fig 37
140 130 120 110 100 90 80 Jan-13
Mar-13
May-13
Jul-13
Sep-13
Mar-13
May-13
Jul-13
Sep-13
Fig 38
115 110 105 100 95 90 Jan-13
MSCI Energy
Energy MSCI India
Fig 39
110 105 100 95 90 85 80 75 70 Jan-13
MSCI Financials
Financials MSCI India
Mar-13
May-13
Jul-13
Sep-13
Mar-13
May-13
Jul-13
Sep-13
Fig 40
130 120 110 100 90 80 70 Jan-13
MSCI Healthcare
Healthcare MSCI India
Fig 41
110 105 100 95 90 85 80 75 70 65 60 Jan-13
MSCI Industrials
Industrials MSCI India
Mar-13
May-13
Jul-13
Sep-13
Mar-13
May-13
Jul-13
Sep-13
Fig 42
160 150 140 130 120 110 100 90 80 70 60 Jan-13
Fig 43
110 105 100 95 90 85 80 75 70 65 60 Jan-13
MSCI Materials
Materials MSCI India
Mar-13
May-13
Jul-13
Sep-13
Mar-13
May-13
Jul-13
Sep-13
4 October 2013
20
Macquarie Research
Eye on India
Fig 44
140 130 120 110 100 90 80 70 60 Jan-13
MSCI Telecom
Telecom MSCI India
Fig 45
110 105 100 95 90 85 80 75 70 65 60 Jan-13
MSCI Utilities
Utilities MSCI India
Mar-13
May-13
Jul-13
Sep-13
Mar-13
May-13
Jul-13
Sep-13
4 October 2013
21
Macquarie Research
Eye on India
11.2 10.8 11.6 8.7 15.2 22.2 17.5 32.3 9.8 17.0 13.1 19.2 15.2
7.9 8.3 10.3 7.4 12.9 18.9 15.5 27.3 8.7 14.4 10.7 17.3 12.6
0.6 1.6 2.7 0.9 1.7 4.1 4.4 9.5 1.3 3.9 1.1 3.7 1.5
0.5 1.3 2.2 0.9 1.6 3.5 3.7 8.9 1.2 3.2 1.0 3.3 1.4
10.2 NA 6.5 3.9 10.4 15.4 12.2 22.2 6.7 17.3 9.0 11.0 9.1
8.3 NA 5.9 3.6 9.2 13.1 10.9 18.8 5.9 14.6 7.7 9.8 7.9
1.4 1.9 1.5 2.5 1.8 0.8 1.5 1.7 2.2 NA 2.1 1.3 1.5
1.7 2.2 1.7 2.7 1.9 0.9 1.7 2.0 2.5 NA 2.2 1.5 1.7
35.1 12.2 10.0 14.2 24.5 13.1 18.3 10.8 30.0 10.8
29.3 10.9 9.1 11.5 19.6 11.1 16.2 9.1 21.1 9.6
10.1 3.2 1.4 2.2 4.1 1.6 4.6 1.1 1.9 1.1
8.9 2.6 1.2 1.9 3.5 1.4 3.9 1.0 1.8 1.0
1.5 1.7 2.2 1.6 0.7 1.8 1.5 1.4 0.3 2.2
1.8 1.9 2.3 2.0 0.8 1.8 1.7 1.6 0.4 2.4
Source: Bloomberg, Macquarie Research, October 2013; Prices as of October 3, 2013 close
Fig 47
MSCI India MSCI China MSCI EM MSCI Europe MSCI Asia ex-Japan MSCI World MSCI US MSCI UK MSCI Japan
Source: Bloomberg, Macquarie Research, October 2013; Prices as of October 3, 2013 close
4 October 2013
22
Macquarie Research
Eye on India
Fig 49
40.0 35.0 30.0 25.0 20.0 15.0 10.0 2000
2002
2004
2006
2008
2010
2012
2002
2004
2006
2008
2010
2012
Fig 50
23.0 19.0 15.0 11.0 7.0 3.0 2000
MSCI Energy
Ratio
10Y Average +1 Stdev -1 Stdev
Fig 51
30.0 25.0 20.0 15.0 10.0 5.0 2000
MSCI Financials
Ratio
10Y Average +1 Stdev -1 Stdev
2002
2004
2006
2008
2010
2012
2002
2004
2006
2008
2010
2012
Fig 52
35.0 30.0 25.0 20.0 15.0 10.0 2000
MSCI Healthcare
Ratio
10Y Average +1 Stdev -1 Stdev
Fig 53
35.0 30.0 25.0 20.0 15.0 10.0 5.0 2000
MSCI Industrials
Ratio
10Y Average +1 Stdev -1 Stdev
2002
2004
2006
2008
2010
2012
2002
2004
2006
2008
2010
2012
Fig 54
30.0 25.0
Fig 55
15.0 13.0 11.0
MSCI Materials
Ratio
10Y Average +1 Stdev -1 Stdev
2004
2006
2008
2010
2012
2002
2004
2006
2008
2010
2012
4 October 2013
23
Macquarie Research
Eye on India
Fig 56
70.0 60.0 50.0 40.0 30.0 20.0 10.0 0.0 2000
MSCI Telecom
Ratio
10Y Average +1 Stdev -1 Stdev
Fig 57
35.0 30.0 25.0 20.0 15.0 10.0 5.0 0.0 2000
MSCI Utilities
Ratio
10Y Average +1 Stdev -1 Stdev
2002
2004
2006
2008
2010
2012
2002
2004
2006
2008
2010
2012
4 October 2013
24
Macquarie Research
Eye on India
Fund Flows
Fig 58 Fund Flows into Equities and Derivatives*
US$ mn FII Net Equity Inflows Domestic MFs, Net equity Investment FII Net Stocks Futures Bought FII Net Index Futures Bought FII Net Derivative Purchases
Oct-07
Jul-08
Apr-09
Jan-10
Oct-10
Jul-11
Apr-12
Jan-13
Fig 60
Fig 61
US$ bn
2.0
10.0
0.0
5.0
-2.0
Apr-12
Jul-12
Oct-12
Jan-13
Apr-13
Jul-13
4 October 2013
25
Macquarie Research
Eye on India
1530 1430 1330 1230 1130 1030 930 830 730 Jan-06
Oct-06
Jul-07
Apr-08
Jan-09
Oct-09
Jul-10
Apr-11
Jan-12
Oct-12
Jul-13
Fig 63
3.00 2.50 2.00 1.50 1.00 0.50
4-Week Earnings Revision Ratio for the Broader Market (BSE-100 Index)
Net Revisions Ratio (x) = (Total Upgrades) / (Total Downgrades)
0.00 Jan-05 Oct-05 Jul-06 Apr-07 Jan-08 Oct-08 Jul-09 Apr-10 Jan-11 Oct-11 Jul-12 Apr-13
4 October 2013
26
Macquarie Research
Eye on India
14-10-2013 Indusind Bank Q2FY14 earnings India WPI data for Sep India CPI data for Sep 21-10-2013 HDFC Ltd Q2FY14 earnings
15-10-2013 TCS Q2FY14 earnings HDFC Bank Q2FY14 earnings Indusind Bank Q2FY14 earnings 22-10-13
18-10-13
24-10-13
30-10-13
*Expected date of release/announcement Source: Company data, Macquarie Research, October 2013
4 October 2013
27
Eye on India
Volatility index definition*
This is calculated from the volatility of historical price movements. Very highhighest risk Stock should be expected to move up or down 60100% in a year investors should be aware this stock is highly speculative. High stock should be expected to move up or down at least 4060% in a year investors should be aware this stock could be speculative. Medium stock should be expected to move up or down at least 3040% in a year. Lowmedium stock should be expected to move up or down at least 2530% in a year. Low stock should be expected to move up or down at least 1525% in a year. * Applicable to Asia/Australian/NZ/Canada stocks only Recommendations 12 months Note: Quant recommendations may differ from Fundamental Analyst recommendations
Financial definitions
All "Adjusted" data items have had the following adjustments made: Added back: goodwill amortisation, provision for catastrophe reserves, IFRS derivatives & hedging, IFRS impairments & IFRS interest expense Excluded: non recurring items, asset revals, property revals, appraisal value uplift, preference dividends & minority interests EPS = adjusted net profit / efpowa* ROA = adjusted ebit / average total assets ROA Banks/Insurance = adjusted net profit /average total assets ROE = adjusted net profit / average shareholders funds Gross cashflow = adjusted net profit + depreciation *equivalent fully paid ordinary weighted average number of shares All Reported numbers for Australian/NZ listed stocks are modelled under IFRS (International Financial Reporting Standards).
Company Specific Disclosures: Important disclosure information regarding the subject companies covered in this report is available at www.macquarie.com/disclosures. Analyst Certification: The views expressed in this research accurately reflect the personal views of the analyst(s) about the subject securities or issuers and no part of the compensation of the analyst(s) was, is, or will be directly or indirectly related to the inclusion of specific recommendations or views in this research. The analyst principally responsible for the preparation of this research receives compensation based on overall revenues of Macquarie Group Ltd ABN 94 122 169 279 (AFSL No. 318062) (MGL) and its related entities (the Macquarie Group) and has taken reasonable care to achieve and maintain independence and objectivity in making any recommendations. General Disclaimers: Macquarie Securities (Australia) Ltd; Macquarie Capital (Europe) Ltd; Macquarie Capital Markets Canada Ltd; Macquarie Capital Markets North America Ltd; Macquarie Capital (USA) Inc; Macquarie Capital Securities Ltd and its Taiwan branch; Macquarie Capital Securities (Singapore) Pte Ltd; Macquarie Securities (NZ) Ltd; Macquarie First South Securities (Pty) Limited; Macquarie Capital Securities (India) Pvt Ltd; Macquarie Capital Securities (Malaysia) Sdn Bhd; Macquarie Securities Korea Limited and Macquarie Securities (Thailand) Ltd are not authorized deposit-taking institutions for the purposes of the Banking Act 1959 (Commonwealth of Australia), and their obligations do not represent deposits or other liabilities of Macquarie Bank Limited ABN 46 008 583 542 (MBL) or MGL. MBL does not guarantee or otherwise provide assurance in respect of the obligations of any of the above mentioned entities. MGL provides a guarantee to the Monetary Authority of Singapore in respect of the obligations and liabilities of Macquarie Capital Securities (Singapore) Pte Ltd for up to SGD 35 million. This research has been prepared for the general use of the wholesale clients of the Macquarie Group and must not be copied, either in whole or in part, or distributed to any other person. If you are not the intended recipient you must not use or disclose the information in this research in any way. If you received it in error, please tell us immediately by return e-mail and delete the document. We do not guarantee the integrity of any e-mails or attached files and are not responsible for any changes made to them by any other person. MGL has established and implemented a conflicts policy at group level (which may be revised and updated from time to time) (the "Conflicts Policy") pursuant to regulatory requirements (including the FSA Rules) which sets out how we must seek to identify and manage all material conflicts of interest. Nothing in this research shall be construed as a solicitation to buy or sell any security or product, or to engage in or refrain from engaging in any transaction. In preparing this research, we did not take into account your investment objectives, financial situation or particular needs. Macquarie salespeople, traders and other professionals may provide oral or written market commentary or trading strategies to our clients that reflect opinions which are contrary to the opinions expressed in this research. Macquarie Research produces a variety of research products including, but not limited to, fundamental analysis, macro-economic analysis, quantitative analysis, and trade ideas. Recommendations contained in one type of research product may differ from recommendations contained in other types of research, whether as a result of differing time horizons, methodologies, or otherwise. Before making an investment decision on the basis of this research, you need to consider, with or without the assistance of an adviser, whether the advice is appropriate in light of your particular investment needs, objectives and financial circumstances. There are risks involved in securities trading. The price of securities can and does fluctuate, and an individual security may even become valueless. International investors are reminded of the additional risks inherent in international investments, such as currency fluctuations and international stock market or economic conditions, which may adversely affect the value of the investment. This research is based on information obtained from sources believed to be reliable but we do not make any representation or warranty that it is accurate, complete or up to date. We accept no obligation to correct or update the information or opinions in it. Opinions expressed are subject to change without notice. No member of the Macquarie Group accepts any liability whatsoever for any direct, indirect, consequential or other loss arising from any use of this research and/or further communication in relation to this research. Clients should contact analysts at, and execute transactions through, a Macquarie Group entity in their home jurisdiction unless governing law permits otherwise. The date and timestamp for above share price and market cap is the closed price of the price date. #CLOSE is the final price at which the security is traded in the relevant exchange on the date indicated. Country-Specific Disclaimers: Australia: In Australia, research is issued and distributed by Macquarie Securities (Australia) Ltd (AFSL No. 238947), a participating organisation of the Australian Securities Exchange. New Zealand: In New Zealand, research is issued and distributed by Macquarie Securities (NZ) Ltd, a NZX Firm. Canada: In Canada, research is prepared, approved and distributed by Macquarie Capital Markets Canada Ltd, a participating organisation of the Toronto Stock Exchange, TSX Venture Exchange & Montral Exchange. Macquarie Capital Markets North America Ltd., which is a registered brokerdealer and member of FINRA, accepts responsibility for the contents of reports issued by Macquarie Capital Markets Canada Ltd in the United States and sent to US persons. Any person wishing to effect transactions in the securities described in the reports issued by Macquarie Capital Markets Canada Ltd should do so with Macquarie Capital Markets North America Ltd. The Research Distribution Policy of Macquarie Capital Markets Canada Ltd is to allow all clients that are entitled to have equal access to our research. United Kingdom: In the United Kingdom, research is issued and
4 October 2013
28
Macquarie Research
Eye on India
distributed by Macquarie Capital (Europe) Ltd, which is authorised and regulated by the Financial Conduct Authority (No. 193905). Germany: In Germany, this research is issued and/or distributed by Macquarie Capital (Europe) Limited, Niederlassung Deutschland, which is authorised and regulated by the UK Financial Conduct Authority (No. 193905). and in Germany by BaFin. France: In France, research is issued and distributed by Macquarie Capital (Europe) Ltd, which is authorised and regulated in the United Kingdom by the Financial Conduct Authority (No. 193905). Hong Kong & Mainland China: In Hong Kong, research is issued and distributed by Macquarie Capital Securities Ltd, which is licensed and regulated by the Securities and Futures Commission. In Mainland China, Macquarie Securities (Australia) Limited Shanghai Representative Office only engages in nonbusiness operational activities excluding issuing and distributing research. Only non-A share research is distributed into Mainland China by Macquarie Capital Securities Ltd. Japan: In Japan, research is issued and distributed by Macquarie Capital Securities (Japan) Limited, a member of the Tokyo Stock Exchange, Inc. and Osaka Securities Exchange Co. Ltd (Financial Instruments Firm, Kanto Financial Bureau (kin-sho) No. 231, a member of Japan Securities Dealers Association and The Financial Futures Association of Japan and Japan Investment Advisers Association). India: In India, research is issued and distributed by Macquarie Capital Securities (India) Pvt Ltd., 92, Level 9, 2 North Avenue, Maker Maxity, Bandra Kurla Complex, Bandra (East), Mumbai 400 051, India, which is a SEBI registered Stock Broker having membership with National Stock Exchange of India Limited (INB231246738) and Bombay Stock Exchange Limited (INB011246734). Malaysia: In Malaysia, research is issued and distributed by Macquarie Capital Securities (Malaysia) Sdn. Bhd. (Company registration number: 463469-W) which is a Participating Organisation of Bursa Malaysia Berhad and a holder of Capital Markets Services License issued by the Securities Commission. Taiwan: In Taiwan, research is issued and distributed by Macquarie Capital Securities Ltd, Taiwan Branch, which is licensed and regulated by the Financial Supervisory Commission. No portion of the report may be reproduced or quoted by the press or any other person without authorisation from Macquarie. Nothing in this research shall be construed as a solicitation to buy or sell any security or product. Research Associate(s) in this report who are registered as Clerks only assist in the preparation of research and are not engaged in writing the research. Thailand: In Thailand, research is produced with the contribution of Kasikorn Securities Public Company Limited, issued and distributed by Macquarie Securities (Thailand) Ltd. Macquarie Securities (Thailand) Ltd. is a licensed securities company that is authorized by the Ministry of Finance, regulated by the Securities and Exchange Commission of Thailand and is an exchange member of the Stock Exchange of Thailand. Macquarie Securities (Thailand) Limited and Kasikorn Securities Public Company Limited have entered into an exclusive strategic alliance agreement to broaden and deepen the scope of services provided to each parties respective clients. The strategic alliance does not constitute a joint venture. The Thai Institute of Directors Association has disclosed the Corporate Governance Report of Thai Listed Companies made pursuant to the policy of the Securities and Exchange Commission of Thailand. Macquarie Securities (Thailand) Ltd does not endorse the result of the Corporate Governance Report of Thai Listed Companies but this Report can be accessed at: http://www.thai-iod.com/en/publications.asp?type=4. South Korea: In South Korea, unless otherwise stated, research is prepared, issued and distributed by Macquarie Securities Korea Limited, which is regulated by the Financial Supervisory Services. Information on analysts in MSKL is disclosed at http://dis.kofia.or.kr/fs/dis2/fundMgr/DISFundMgrAnalystPop.jsp?companyCd2=A03053&pageDiv=02. South Africa: In South Africa, research is issued and distributed by Macquarie First South Securities (Pty) Limited, a member of the JSE Limited. Singapore: In Singapore, research is issued and distributed by Macquarie Capital Securities (Singapore) Pte Ltd (Company Registration Number: 198702912C), a Capital Markets Services license holder under the Securities and Futures Act to deal in securities and provide custodial services in Singapore. Pursuant to the Financial Advisers (Amendment) Regulations 2005, Macquarie Capital Securities (Singapore) Pte Ltd is exempt from complying with sections 25, 27 and 36 of the Financial Advisers Act. All Singapore-based recipients of research produced by Macquarie Capital (Europe) Limited, Macquarie Capital Markets Canada Ltd, Macquarie First South Securities (Pty) Limited and Macquarie Capital (USA) Inc. represent and warrant that they are institutional investors as defined in the Securities and Futures Act. United States: In the United States, research is issued and distributed by Macquarie Capital (USA) Inc., which is a registered broker-dealer and member of FINRA. Macquarie Capital (USA) Inc, accepts responsibility for the content of each research report prepared by one of its non-US affiliates when the research report is distributed in the United States by Macquarie Capital (USA) Inc. Macquarie Capital (USA) Inc.s affiliates analysts are not registered as research analysts with FINRA, may not be associated persons of M acquarie Capital (USA) Inc., and therefore may not be subject to FINRA rule restrictions on communications with a subject company, public appearances, and trading securities held by a research analyst account. Information regarding futures is provided for reference purposes only and is not a solicitation for purchases or sales of futures. Any persons receiving this report directly from Macquarie Capital (USA) Inc. and wishing to effect a transaction in any security described herein should do so with Macquarie Capital (USA) Inc. Important disclosure information regarding the subject companies covered in this report is available at www.macquarie.com/research/disclosures, or contact your registered representative at 1-888-MAC-STOCK, or write to the Supervisory Analysts, Research Department, Macquarie Securities, 125 W.55th Street, New York, NY 10019. Macquarie Group
Auckland Tel: (649) 377 6433 Jakarta Tel: (62 21) 515 1818 Bangkok Tel: (662) 694 7999 Johannesburg Tel: (2711) 583 2000 Calgary Tel: (1 403) 218 6650 Kuala Lumpur Tel: (60 3) 2059 8833 Denver Tel: (303) 952 2800 Frankfurt Geneva Tel: (069) 509 578 000 Tel: (41) 22 818 7777 Melbourne Tel: (613) 9635 8139 Seoul Tel: (82 2) 3705 8500 Hong Kong Tel: (852) 2823 3588 Montreal Tel: (1 514) 925 2850 Shanghai Tel: (86 21) 6841 3355
London Manila Tel: (44 20) 3037 2000 Tel: (63 2) 857 0888 Paris Tel: (33 1) 7842 3823 Perth Tel: (618) 9224 0888 Toronto Tel: (1 416) 848 3500
Mumbai Munich New York Tel: (91 22) 6653 3000 Tel: (089) 2444 31800 Tel: (1 212) 231 2500 Singapore Tel: (65) 6601 1111 Sydney Tel: (612) 8232 9555
Taipei Tokyo Tel: (886 2) 2734 7500 Tel: (81 3) 3512 7900
Available to clients on the world wide web at www.macquarieresearch.com and through Thomson Financial, FactSet, Reuters, Bloomberg, and CapitalIQ.
4 October 2013
29
Asia Research
Head of Equity Research
John OConnell (Global Head) Peter Redhead (Asia Head) (612) 8232 7544 (852) 3922 4836 (852) 3922 5417 (8621) 2412 9006 (9122) 6720 4084 (813) 3512 7856 (82 2) 3705 8644 (852) 3922 4774 (9122) 6720 4078 (6221) 2598 8366 (813) 3512 7476 (822) 3705 8643 (65) 6601 0981 (632) 857 0899 (632) 857 0892 (8862) 2734 7530 (662) 694 7728 (632) 857 0899 (632) 857 0892 (65) 6601 0840 (852) 3922 3557 (852) 3922 4068 (852) 3922 1147 (9122) 6720 4084 (6221) 2598 8489 (813) 3512 7392 (822) 3705 8678 (632) 857 0899 (65) 6601 0840 (662) 694 7993 (8621) 2412 9007 (852) 3922 4626 (813) 3512 7920 (852) 3922 5417 (8621) 2412 9082 (852) 3922 3585 (9122) 6720 4087 (6221) 2598 8398 (813) 3512 7871 (822) 3705 8661 (603) 2059 8993 (662) 694 7753 (852) 3922 3567 (822) 2095 7222 (813) 3512 7880 (852) 3922 3566 (852) 3922 3578 (9122) 6720 4090 (813) 3512 7875 (603) 2059 8989
Automobiles/Auto Parts
Janet Lewis (China) Zhixuan Lin (China) Amit Mishra (India) Clive Wiggins (Japan) Michael Sohn (Korea) Ismael Pili (Asia, Hong Kong, China) Suresh Ganapathy (India) Nicolaos Oentung (Indonesia) Alastair Macdonald (Japan) Chan Hwang (Korea) Matthew Smith (Malaysia, Singapore) Alex Pomento (Philippines) Gilbert Lopez (Philippines) Dexter Hsu (Taiwan) Passakorn Linmaneechote (Thailand)
Commodities
Colin Hamilton (Global) Jim Lennon Duncan Hobbs Graeme Train Rakesh Arora
Economics
Peter Eadon-Clarke (Asia, Japan) Aimee Kaye (ASEAN) Richard Gibbs (Australia) Tanvee Gupta (India)
Conglomerates
Alex Pomento (Philippines) Gilbert Lopez (Philippines) Somesh Agarwal (Singapore)
Quantitative / CPG
Gurvinder Brar (Global) Josh Holcroft (Asia). Burke Lau (Asia) Simon Rigney (Asia, Japan) Eric Yeung (Asia) Suni Kim (Japan)
Strategy/Country
Viktor Shvets (Asia) Chetan Seth (Asia) Joshua van Lin (Asia Micro) Peter Eadon-Clarke (Japan) David Ng (China, Hong Kong) Jiong Shao (China) Rakesh Arora (India) Nicolaos Oentung (Indonesia) Chan Hwang (Korea) Yeonzon Yeow (Malaysia) Alex Pomento (Philippines) Conrad Werner (Singapore) Daniel Chang (Taiwan) David Gambrill (Thailand)
Technology
Jeffrey Su (Asia, Taiwan) Steve Zhang (China, Hong Kong) Nitin Mohta (India) Claudio Aritomi (Japan) Damian Thong (Japan) David Gibson (Japan) George Chang (Japan) Daniel Kim (Korea) Soyun Shin (Korea) Daniel Chang (Taiwan) Ellen Tseng (Taiwan) Tammy Lai (Taiwan)
Emerging Leaders
Jake Lynch (China, Asia) Adam Worthington (ASEAN) Michael Newman (Japan)
Industrials
Janet Lewis (Asia) Patrick Dai (China) Saiyi He (China) Inderjeetsingh Bhatia (India) Andy Lesmana (Indonesia) Kenjin Hotta (Japan) Juwon Lee (Korea) Sunaina Dhanuka (Malaysia) David Gambrill (Thailand)
Telecoms
Nathan Ramler (Asia, Japan) Danny Chu (China, Hong Kong) Riaz Hyder (Indonesia) Prem Jearajasingam (Malaysia, Singapore) Aaron Salvador (Philippines) Joseph Quinn (Taiwan)
Insurance
Scott Russell (Asia, Japan) Chung Jun Yun (Korea)
Asia Sales
Regional Heads of Sales
Robin Black (Asia) Chris Gray (ASEAN) Peter Slater (Boston) Jeffrey Shiu (China & Hong Kong) Thomas Renz (Geneva) Bharat Rawla (India) Jurgan Usman (Indonesia) Miki Edelman (Japan) John Jay Lee (Korea) Ruben Boopalan (Malaysia) Gino C Rojas (Philippines) Eric Roles (New York) Paul Colaco (New York) (852) 3922 2074 (65) 6601 0288 (1 617) 598 2502 (852) 3922 2061 (41) 22 818 7712 (9122) 6720 4100 (6221) 515 1555 (813) 3512 7857 (822) 3705 9988 (603) 2059 8888 (632) 857 0861 (1 212) 231 2559 (1 212) 231 2496